# Otezla

NDC: 55513-508
Generic name: apremilast
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20240425

FDA application: NDA205437

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-508"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-508
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6b1f516-4972-4d82-bced-113e47b41cc5